单位:[1]Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China华中科技大学同济医学院附属同济医院外科学系胆胰外科
This study was funded by The National Natural Science Foundation of China (Grants No. 81272659 and 81772950 to Renyi Qin, Grant No. 81602475 to Xingjun Guo Grant No. 81772950 to Min Wang) and the Research Fund of Young Scholars for the Doctoral Program of Higher Education of China (No. 20110142120014 to Renyi Qin, No. 20120142110055 to Min Wang).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|2 区医学
小类|2 区肿瘤学3 区细胞生物学
最新[2025]版:
无
第一作者:
第一作者单位:[1]Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
通讯作者:
推荐引用方式(GB/T 7714):
Zhao Y,Shen M,Feng Y,et al.Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1/PD-L1 pathway[J].Oncotarget.2018,9(19):14803-14814.doi:10.18632/oncotarget.22976.
APA:
Zhao, Y,Shen, M,Feng, Y,He, R,Xu, X...&Qin, R.(2018).Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1/PD-L1 pathway.Oncotarget,9,(19)
MLA:
Zhao, Y,et al."Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1/PD-L1 pathway".Oncotarget 9..19(2018):14803-14814